Treatment of HR+/HER2- breast cancer in urban mainland China: results from the CancerMPact Survey 2019. Murali B, Durbin L, Vijaykumar S, Yang L, et al. Breast Cancer Res Treat 2022 Aug 20. pii: 10.1007/s10549-022-06709.

Read + Share

Amedeo Smart

Independent Medical Education

Murali B, Durbin L, Vijaykumar S, Yang L, et al. Treatment of HR+/HER2- breast cancer in urban mainland China: results from the CancerMPact Survey 2019. Breast Cancer Res Treat 2022 Aug 20. pii: 10.1007/s10549-022-06709.
PMID: 35986800